Conduent (CNDT) Competitors

$1.55 +0.16 (+11.51%)

Closing price 04:00 PM Eastern

Extended Trading

$1.54 -0.01 (-0.32%)

As of 07:47 PM Eastern

CNDT vs. UPWK, DFIN, LZ, GDRX, and NUTX

Should you buy Conduent stock or one of its competitors? MarketBeat compares Conduent with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Conduent include Upwork (UPWK), Donnelley Financial Solutions (DFIN), LegalZoom.com (LZ), GoodRx (GDRX), and Nutex Health (NUTX). These companies are all part of the "business services" industry.

How does Conduent compare to Upwork?

Conduent (NASDAQ:CNDT) and Upwork (NASDAQ:UPWK) are both small-cap business services companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, valuation, profitability, media sentiment, risk, dividends, earnings and institutional ownership.

Upwork has lower revenue, but higher earnings than Conduent. Conduent is trading at a lower price-to-earnings ratio than Upwork, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Conduent	$3.04B	0.08	-$170M	-$1.02	N/A
Upwork	$787.78M	1.37	$115.43M	$0.81	10.80

Conduent has a beta of 1.43, indicating that its share price is 43% more volatile than the broader market. Comparatively, Upwork has a beta of 1.07, indicating that its share price is 7% more volatile than the broader market.

Upwork has a consensus target price of $16.20, indicating a potential upside of 85.14%. Given Upwork's higher probable upside, analysts clearly believe Upwork is more favorable than Conduent.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Conduent	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	2 Strong Buy rating(s)	3.00
Upwork	0 Sell rating(s)	10 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.23

Upwork has a net margin of 13.81% compared to Conduent's net margin of -5.04%. Upwork's return on equity of 17.92% beat Conduent's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Conduent	-5.04%	-7.08%	-2.04%
Upwork	13.81%	17.92%	8.54%

In the previous week, Upwork had 2 more articles in the media than Conduent. MarketBeat recorded 16 mentions for Upwork and 14 mentions for Conduent. Conduent's average media sentiment score of 0.47 beat Upwork's score of -0.04 indicating that Conduent is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Conduent	2 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Upwork	2 Very Positive mention(s)	1 Positive mention(s)	6 Neutral mention(s)	3 Negative mention(s)	4 Very Negative mention(s)	Neutral

77.3% of Conduent shares are held by institutional investors. Comparatively, 77.7% of Upwork shares are held by institutional investors. 1.9% of Conduent shares are held by insiders. Comparatively, 7.6% of Upwork shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

Upwork beats Conduent on 12 of the 17 factors compared between the two stocks.

How does Conduent compare to Donnelley Financial Solutions?

Donnelley Financial Solutions (NYSE:DFIN) and Conduent (NASDAQ:CNDT) are both small-cap business services companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, analyst recommendations, dividends, media sentiment, institutional ownership, earnings, risk and valuation.

Donnelley Financial Solutions presently has a consensus price target of $59.50, indicating a potential upside of 51.61%. Given Donnelley Financial Solutions' higher possible upside, analysts clearly believe Donnelley Financial Solutions is more favorable than Conduent.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Donnelley Financial Solutions	0 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.80
Conduent	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	2 Strong Buy rating(s)	3.00

Donnelley Financial Solutions has a beta of 0.83, meaning that its share price is 17% less volatile than the broader market. Comparatively, Conduent has a beta of 1.43, meaning that its share price is 43% more volatile than the broader market.

Donnelley Financial Solutions has higher earnings, but lower revenue than Conduent. Conduent is trading at a lower price-to-earnings ratio than Donnelley Financial Solutions, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Donnelley Financial Solutions	$767M	1.28	$32.40M	$1.29	30.42
Conduent	$3.04B	0.08	-$170M	-$1.02	N/A

Donnelley Financial Solutions has a net margin of 4.52% compared to Conduent's net margin of -5.04%. Donnelley Financial Solutions' return on equity of 24.80% beat Conduent's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Donnelley Financial Solutions	4.52%	24.80%	11.99%
Conduent	-5.04%	-7.08%	-2.04%

93.8% of Donnelley Financial Solutions shares are held by institutional investors. Comparatively, 77.3% of Conduent shares are held by institutional investors. 5.2% of Donnelley Financial Solutions shares are held by insiders. Comparatively, 1.9% of Conduent shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, Conduent had 10 more articles in the media than Donnelley Financial Solutions. MarketBeat recorded 14 mentions for Conduent and 4 mentions for Donnelley Financial Solutions. Conduent's average media sentiment score of 0.47 beat Donnelley Financial Solutions' score of 0.47 indicating that Conduent is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Donnelley Financial Solutions	0 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Conduent	2 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Donnelley Financial Solutions beats Conduent on 11 of the 17 factors compared between the two stocks.

How does Conduent compare to LegalZoom.com?

Conduent (NASDAQ:CNDT) and LegalZoom.com (NASDAQ:LZ) are both small-cap business services companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, dividends, valuation, profitability, risk, analyst recommendations, media sentiment and institutional ownership.

LegalZoom.com has a net margin of 1.46% compared to Conduent's net margin of -5.04%. LegalZoom.com's return on equity of 11.53% beat Conduent's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Conduent	-5.04%	-7.08%	-2.04%
LegalZoom.com	1.46%	11.53%	3.93%

In the previous week, Conduent had 1 more articles in the media than LegalZoom.com. MarketBeat recorded 14 mentions for Conduent and 13 mentions for LegalZoom.com. LegalZoom.com's average media sentiment score of 0.78 beat Conduent's score of 0.47 indicating that LegalZoom.com is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Conduent	2 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
LegalZoom.com	3 Very Positive mention(s)	2 Positive mention(s)	8 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

LegalZoom.com has a consensus target price of $9.25, suggesting a potential upside of 40.58%. Given LegalZoom.com's higher possible upside, analysts plainly believe LegalZoom.com is more favorable than Conduent.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Conduent	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	2 Strong Buy rating(s)	3.00
LegalZoom.com	3 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.00

LegalZoom.com has lower revenue, but higher earnings than Conduent. Conduent is trading at a lower price-to-earnings ratio than LegalZoom.com, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Conduent	$3.04B	0.08	-$170M	-$1.02	N/A
LegalZoom.com	$779.71M	1.45	$15.43M	$0.06	109.67

77.3% of Conduent shares are held by institutional investors. Comparatively, 82.0% of LegalZoom.com shares are held by institutional investors. 1.9% of Conduent shares are held by insiders. Comparatively, 5.9% of LegalZoom.com shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Conduent has a beta of 1.43, suggesting that its share price is 43% more volatile than the broader market. Comparatively, LegalZoom.com has a beta of 1.33, suggesting that its share price is 33% more volatile than the broader market.

Summary

LegalZoom.com beats Conduent on 12 of the 17 factors compared between the two stocks.

How does Conduent compare to GoodRx?

GoodRx (NASDAQ:GDRX) and Conduent (NASDAQ:CNDT) are both small-cap business services companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, institutional ownership, risk, earnings, analyst recommendations, dividends, media sentiment and profitability.

GoodRx has higher earnings, but lower revenue than Conduent. Conduent is trading at a lower price-to-earnings ratio than GoodRx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
GoodRx	$796.85M	1.07	$30.44M	$0.06	41.67
Conduent	$3.04B	0.08	-$170M	-$1.02	N/A

GoodRx has a net margin of 2.61% compared to Conduent's net margin of -5.04%. GoodRx's return on equity of 7.90% beat Conduent's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
GoodRx	2.61%	7.90%	3.23%
Conduent	-5.04%	-7.08%	-2.04%

63.8% of GoodRx shares are held by institutional investors. Comparatively, 77.3% of Conduent shares are held by institutional investors. 5.9% of GoodRx shares are held by company insiders. Comparatively, 1.9% of Conduent shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

GoodRx has a beta of 1.54, indicating that its stock price is 54% more volatile than the broader market. Comparatively, Conduent has a beta of 1.43, indicating that its stock price is 43% more volatile than the broader market.

In the previous week, Conduent had 10 more articles in the media than GoodRx. MarketBeat recorded 14 mentions for Conduent and 4 mentions for GoodRx. GoodRx's average media sentiment score of 0.99 beat Conduent's score of 0.47 indicating that GoodRx is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
GoodRx	0 Very Positive mention(s)	4 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Conduent	2 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

GoodRx currently has a consensus price target of $3.81, suggesting a potential upside of 52.50%. Given GoodRx's higher probable upside, equities analysts plainly believe GoodRx is more favorable than Conduent.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
GoodRx	3 Sell rating(s)	7 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.13
Conduent	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	2 Strong Buy rating(s)	3.00

Summary

GoodRx beats Conduent on 12 of the 17 factors compared between the two stocks.

How does Conduent compare to Nutex Health?

Nutex Health (NASDAQ:NUTX) and Conduent (NASDAQ:CNDT) are both small-cap business services companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, dividends, earnings, media sentiment, risk, institutional ownership, profitability and analyst recommendations.

5.3% of Nutex Health shares are owned by institutional investors. Comparatively, 77.3% of Conduent shares are owned by institutional investors. 44.7% of Nutex Health shares are owned by insiders. Comparatively, 1.9% of Conduent shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Nutex Health has a net margin of 10.95% compared to Conduent's net margin of -5.04%. Nutex Health's return on equity of 23.50% beat Conduent's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nutex Health	10.95%	23.50%	10.47%
Conduent	-5.04%	-7.08%	-2.04%

In the previous week, Conduent had 13 more articles in the media than Nutex Health. MarketBeat recorded 14 mentions for Conduent and 1 mentions for Nutex Health. Nutex Health's average media sentiment score of 0.93 beat Conduent's score of 0.47 indicating that Nutex Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Nutex Health	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Conduent	2 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Nutex Health has higher earnings, but lower revenue than Conduent. Conduent is trading at a lower price-to-earnings ratio than Nutex Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nutex Health	$875.26M	0.98	$70.79M	$12.94	9.64
Conduent	$3.04B	0.08	-$170M	-$1.02	N/A

Nutex Health currently has a consensus price target of $205.00, indicating a potential upside of 64.39%. Given Nutex Health's higher possible upside, equities analysts clearly believe Nutex Health is more favorable than Conduent.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nutex Health	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50
Conduent	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	2 Strong Buy rating(s)	3.00

Nutex Health has a beta of 0.25, suggesting that its stock price is 75% less volatile than the broader market. Comparatively, Conduent has a beta of 1.43, suggesting that its stock price is 43% more volatile than the broader market.

Summary

Nutex Health beats Conduent on 11 of the 17 factors compared between the two stocks.

Get Conduent News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CNDT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CNDT vs. The Competition

Export

Metric	Conduent	Outsourcing Industry	Business Sector	NASDAQ Exchange
Market Cap	$215.59M	$3.34B	$6.40B	$12.28B
Dividend Yield	N/A	2.14%	3.20%	5.30%
P/E Ratio	-1.52	9.56	30.10	25.24
Price / Sales	0.08	0.65	421.07	74.54
Price / Cash	1.59	6.29	22.08	37.27
Price / Book	0.35	6.99	6.02	6.63
Net Income	-$170M	$263.73M	$204.78M	$335.41M
7 Day Performance	-8.82%	-5.52%	1.86%	-1.83%
1 Month Performance	-4.91%	-15.08%	-4.08%	-1.16%
1 Year Performance	-31.11%	-36.92%	30.16%	28.31%

Conduent Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CNDT Conduent	2.8325 of 5 stars	$1.55 +11.5%	N/A	-38.2%	$215.59M	$3.04B	N/A	51,000	Earnings Report
UPWK Upwork	4.0144 of 5 stars	$8.81 -0.1%	$16.20 +83.9%	-52.6%	$1.09B	$787.78M	10.88	850
DFIN Donnelley Financial Solutions	4.0245 of 5 stars	$41.91 -2.2%	$59.50 +42.0%	-30.0%	$1.07B	$767M	32.49	1,750
LZ LegalZoom.com	4.2237 of 5 stars	$6.10 -0.5%	$9.25 +51.6%	-35.4%	$1.05B	$756.04M	101.68	1,196
GDRX GoodRx	4.4261 of 5 stars	$2.84 -2.7%	$3.77 +32.8%	-38.6%	$1.00B	$787.89M	47.34	950

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:CNDT) was last updated on 5/18/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Conduent (CNDT) Competitors

CNDT vs. UPWK, DFIN, LZ, GDRX, and NUTX

How does Conduent compare to Upwork?

Summary

How does Conduent compare to Donnelley Financial Solutions?

Summary

How does Conduent compare to LegalZoom.com?

Summary

How does Conduent compare to GoodRx?

Summary

How does Conduent compare to Nutex Health?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CNDT vs. The Competition

Conduent Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Conduent (CNDT) Competitors

CNDT vs. UPWK, DFIN, LZ, GDRX, and NUTX

How does Conduent compare to Upwork?

Which has stronger earnings & valuation, CNDT or UPWK?

Which has more volatility & risk, CNDT or UPWK?

Do analysts rate CNDT or UPWK?

Is CNDT or UPWK more profitable?

Does the media prefer CNDT or UPWK?

Do institutionals & insiders hold more shares of CNDT or UPWK?

Summary

How does Conduent compare to Donnelley Financial Solutions?

Do analysts rate DFIN or CNDT?

Which has more risk and volatility, DFIN or CNDT?

Which has preferable earnings and valuation, DFIN or CNDT?

Is DFIN or CNDT more profitable?

Do insiders & institutionals believe in DFIN or CNDT?

Does the media favor DFIN or CNDT?

Summary

How does Conduent compare to LegalZoom.com?

Is CNDT or LZ more profitable?

Does the media refer more to CNDT or LZ?

Do analysts recommend CNDT or LZ?

Which has higher earnings & valuation, CNDT or LZ?

Do insiders and institutionals hold more shares of CNDT or LZ?

Which has more risk and volatility, CNDT or LZ?

Summary

How does Conduent compare to GoodRx?

Which has better earnings & valuation, GDRX or CNDT?

Is GDRX or CNDT more profitable?

Do insiders & institutionals have more ownership in GDRX or CNDT?

Which has more volatility and risk, GDRX or CNDT?

Does the media favor GDRX or CNDT?

Do analysts prefer GDRX or CNDT?

Summary

How does Conduent compare to Nutex Health?

Do institutionals & insiders hold more shares of NUTX or CNDT?

Is NUTX or CNDT more profitable?

Does the media favor NUTX or CNDT?

Which has higher earnings and valuation, NUTX or CNDT?

Do analysts rate NUTX or CNDT?

Which has more risk & volatility, NUTX or CNDT?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CNDT vs. The Competition

Conduent Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools